Showing results (4991-5000 of 9,342) with videos related to
Sort By:
Pageof 935
Cancer Medicine|June 1, 2017
Comparison of annual percentage change in breast cancer incidence rate between Taiwan and the United States-A smoothed Lexis diagram approachLi-Hsin Chien, Tzu-Jui Tseng, Chung-Hsing Chen, et al.Cancer Medicine|June 1, 2017
Long-term quality of life after definitive treatment for prostate cancer: patient-reported outcomes in the second posttreatment decadeJoanne W Jang, Michael R Drumm, Jason A Efstathiou, et al.Cancer Medicine|June 3, 2017
In vitro additive antitumor effects of dimethoxycurcumin and 5-fluorouracil in colon cancer cellsHuiying Zhao, Qingchun Liu, Saisai Wang, et al.Cancer Medicine|September 15, 2016
Symptom clusters and survival in Portuguese patients with advanced cancerPedro C Barata, Alice Cardoso, Maria P Custodio, et al.Cancer Medicine|September 16, 2016
Associations between cancer and Alzheimer's disease in a U.S. Medicare populationDaryl Michal Freedman, Jincao Wu, Honglei Chen, et al.Cancer Medicine|June 6, 2017
Cervical cancer screening in a low-resource setting: a pilot study on an HPV-based screen-and-treat approachMargot Kunckler, Fanny Schumacher, Bruno Kenfack, et al.Cancer Medicine|October 25, 2021
First-line sorafenib sequential therapy and liver disease etiology for unresectable hepatocellular carcinoma using inverse probability weighting: A multicenter retrospective studyShigeo Shimose, Atsushi Hiraoka, Masahito Nakano, et al.Cancer Medicine|October 27, 2021
Definitive concurrent chemoradiotherapy with paclitaxel plus carboplatin is superior to cisplatin plus 5-fluorouracil in patients with inoperable esophageal squamous cell carcinoma using retrospective, real-world evidenceJason Chia-Hsun Hsieh, Pin-Chun Chiang, Tsung-Min Hung, et al.Cancer Medicine|February 4, 2022
Global burden of primary liver cancer by five etiologies and global prediction by 2035 based on global burden of disease study 2019Yuan Liu, Jinxin Zheng, Jialing Hao, et al.Cancer Medicine|October 19, 2021
Interleukin-33 as an early predictor of cetuximab treatment efficacy in patients with colorectal cancerXujun Zhang, Kefan Bi, Xiaoxuan Tu, et al.Pageof 935